Prof. Dr. med. Peter Fasching

Professur für Translationale Frauenheilkunde und Geburtshilfe

ABC7 Consensus: Assessment by a German Group of Experts (2024) Ditsch N, Untch M, Fasching P, Busch S, Ettl J, Haidinger R, Jackisch C, et al. Journal article BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing (2024) Arun B, Couch FJ, Abraham J, Tung N, Fasching P Journal article, Review article Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset (2024) Davidson AL, Michailidou K, Parsons MT, Fortuno C, Bolla MK, Wang Q, Dennis J, et al. Journal article Update Breast Cancer 2024 Part 1 - Expert Opinion on Advanced Breast Cancer (2024) Würstlein R, Kolberg HC, Hartkopf AD, Fehm TN, Welslau M, Schütz F, Fasching P, et al. Journal article Correlation of RANK and RANKL with mammographic density in primary breast cancer patients (2024) Wunderle M, Heindl F, Behrens A, Häberle L, Hack C, Heusinger K, Hübner H, et al. Journal article Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions (2024) Dareng EO, Coetzee SG, Tyrer JP, Peng PC, Rosenow W, Chen S, Davis BD, et al. Journal article Quality-Assured Analysis of PIK3CA Mutations in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer Tissue: A Story About the Need for Proficiency Testing for High-Quality Molecular Biomarker Reporting in Precision Medicine (2024) Schmidt C, Stöhr R, Dimitrova L, Beckmann M, Rübner M, Fasching P, Denkert C, et al. Journal article Radiotherapy statements of the 18th St. Gallen International Breast Cancer Consensus Conference—a German expert perspective (2024) Krug D, Banys-Paluchowski M, Brucker SY, Denkert C, Ditsch N, Fasching P, Haidinger R, et al. Journal article, Review article Disentangling the relationships of body mass index and circulating sex hormone concentrations in mammographic density using Mendelian randomization (2024) Haas CB, Chen H, Harrison T, Fan S, Gago-Dominguez M, Castelao JE, Bolla MK, et al. Journal article Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522 (2024) Pusztai L, Denkert C, O'Shaughnessy J, Cortes J, Dent R, McArthur H, Kümmel S, et al. Journal article